secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptiNose, Inc. (—)
CIK:        0001494650
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001494650-24-000137
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Catherine Owen resigns from OptiNose board to become CEO of Acadia Pharmaceuticals
--------------------------------------------------------------------------------

- Catherine Owen resigned from the OptiNose board effective September 24, 2024.
- Resignation was not due to any disagreement with the company on operations, policies, or practices.
- Owen has been appointed Chief Executive Officer of Acadia Pharmaceuticals (NASDAQ: ACAD).
- No successor was announced; board size is reduced accordingly.
- OptiNose thanked Owen for her service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494650/000149465024000137/0001494650-24-000137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494650/000149465024000137/optn-20240924.htm
  HTML page:      https://secwatch.observer/filing/0001494650-24-000137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer